Russell Investments Group Ltd. Has $240.86 Million Position in Oracle Corporation (NYSE:ORCL)

Key Points

• Russell Investments Group Ltd. has decreased its stake in Oracle Corporation by 6.6%, selling 121,142 shares, maintaining a position worth approximately $240.86 million.
• Several institutional investors have modified their stakes in Oracle, with 42.44% of the company currently held by such investors.
• Oracle announced a quarterly dividend of $0.50 per share, resulting in an annualized yield of 0.8%, and has a current dividend payout ratio of 46.08%.

Russell Investments Group Ltd. trimmed its position in Oracle Corporation (NYSE:ORCL - Free Report) by 6.6% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,721,174 shares of the enterprise software provider's stock after selling 121,142 shares during the quarter. Russell Investments Group Ltd. owned 0.06% of Oracle worth $240,860,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of the stock. Sunbeam Capital Management LLC acquired a new stake in Oracle in the fourth quarter valued at approximately $30,000. Redmont Wealth Advisors LLC bought a new stake in Oracle during the first quarter worth $27,000. Inlight Wealth Management LLC bought a new stake in shares of Oracle in the first quarter valued at $28,000. Iron Horse Wealth Management LLC grew its position in shares of Oracle by 284.9% in the first quarter. Iron Horse Wealth Management LLC now owns 204 shares of the enterprise software provider's stock valued at $29,000 after purchasing an additional 151 shares in the last quarter. Finally, Mpwm Advisory Solutions LLC purchased a new position in Oracle during the fourth quarter worth about $36,000. 42.44% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Oracle news, insider Michael D. Sicilia sold 15,880 shares of the firm's stock in a transaction that occurred on Tuesday, August 5th. The shares were sold at an average price of $254.48, for a total value of $4,041,142.40. Following the completion of the transaction, the insider owned 99,212 shares of the company's stock, valued at $25,247,469.76. This trade represents a 13.80% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Naomi O. Seligman sold 3,303 shares of the firm's stock in a transaction on Wednesday, July 16th. The shares were sold at an average price of $233.32, for a total transaction of $770,655.96. Following the completion of the sale, the director owned 31,447 shares in the company, valued at $7,337,214.04. The trade was a 9.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 444,183 shares of company stock worth $86,521,198 over the last three months. 42.20% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on ORCL shares. Barclays reiterated an "overweight" rating and issued a $221.00 price objective (up from $202.00) on shares of Oracle in a report on Friday, June 13th. Stifel Nicolaus upgraded Oracle from a "hold" rating to a "buy" rating and upped their price target for the stock from $180.00 to $250.00 in a research note on Monday, June 30th. Piper Sandler upgraded Oracle from a "neutral" rating to an "overweight" rating and increased their target price for the company from $190.00 to $270.00 in a research note on Thursday, July 10th. Loop Capital set a $135.00 price target on Oracle in a report on Tuesday, June 10th. Finally, Oppenheimer reaffirmed an "outperform" rating on shares of Oracle in a report on Wednesday, June 18th. Nine analysts have rated the stock with a hold rating, twenty-three have assigned a buy rating and three have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $222.75.

Oracle Stock Performance

NYSE:ORCL opened at $253.00 on Tuesday. The company has a debt-to-equity ratio of 4.07, a quick ratio of 0.75 and a current ratio of 0.75. The stock has a market capitalization of $710.63 billion, a P/E ratio of 58.29, a PEG ratio of 3.73 and a beta of 1.43. The company has a 50 day moving average price of $224.37 and a 200 day moving average price of $178.23. Oracle Corporation has a fifty-two week low of $118.86 and a fifty-two week high of $260.87.

Oracle (NYSE:ORCL - Get Free Report) last issued its quarterly earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, beating the consensus estimate of $1.64 by $0.06. Oracle had a net margin of 21.68% and a return on equity of 87.34%. The company had revenue of $15.90 billion during the quarter, compared to analysts' expectations of $15.58 billion. During the same quarter last year, the company posted $1.63 EPS. The firm's revenue was up 11.3% compared to the same quarter last year. Equities research analysts forecast that Oracle Corporation will post 5 EPS for the current year.

Oracle Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, July 24th. Shareholders of record on Thursday, July 10th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend was Thursday, July 10th. Oracle's dividend payout ratio (DPR) is currently 46.08%.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.